Quarterly EPS earnings growth: Vermillion (AWH)

Symbol and logo of brand Aspira Women's Health (AWH)

Aspira Women's Health (AWH) has localized sample processing, although its bioinformatics rely on third-party cloud services. The quarterly EPS trajectory demonstrates financial momentum, where the value of 0.00 serves as the current metric. Aspira Women's Health generates revenue from early ovarian cancer diagnostics, although revenue scaling is constrained by slow reimbursement approvals from US insurance funds.

Aspira Women's Health Inc. (AWH) Year-over-year net earnings per share change for the last twelve months: for the period 07/04/2022 - 04/26/2025

Summary analytical data breakdowns for aspirawh.com (AWH)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Summary company analytics:Aspira Women's Health, Inc. - AWH
Flagship merchandise of Aspira Women's Health

Cloud infrastructure outsourcing allows Aspira Women's Health (AWH) to minimize capital expenditures by redirecting resources toward the development of data analytics. By analyzing the quarterly EPS growth trend, an investor assesses the rate of change in net income per share, which enables the identification of business scaling speeds and confirms fundamental capital stability without waiting for official financial reports.

Competitor analysis

A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months illumina.com|Exact Sciences (EXAS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Revvity (RVTY)|Year-over-year net earnings per share change for the last twelve months Bio-Rad Laboratories, Inc.|Year-over-year earnings per share growth for the last twelve months Anbio Biotechnology NNNN|Year-over-year earnings per share growth rate for the last twelve months SHC (Sterigenics)|quidel.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months OPKO Health|CDNA: Quarterly EPS earnings growth|Maravai LifeSciences Corp (MRVI) - Quarterly EPS earnings growth|FLGT (fulgentgenetics.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Standard BioTools Corp|Year-over-year net earnings per share growth for the last 12 months CTKB (Cytek Biosciences, Inc.)|OSUR (OraSure Technologies) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth XGN (exagen.com)|MDxHealth Inc. - Year-over-year earnings per share growth for the last twelve months|Lucid Diagnostics, Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Prenetics Global Limited PRE|Insight Molecular (IMDX) - Year-over-year earnings per share growth for the last twelve months|TRIB (Trinity Biotech PLC) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months ProPhase Labs|Ainos (AIMD) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CODX (Co-Diagnostics)|HSCS (Heart Test Labs) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Biomerica BMRA|CDIO: Year-over-year earnings per share growth for the last 12 months|Onconetix Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Virax Biolabs Group Ltd VRAX|bluejaydx.com (BJDX) - Year-over-year earnings per share growth for the last twelve months|Accelerate Diagnostics, Inc (AXDX) - Quarterly EPS earnings growth|CNTG (CENTOGENE, N.V.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Enzo Biochem (ENZ)|Year-over-year net earnings per share growth for the last 12 months FRES (fresh2.co)|GENE - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months 23andMe Inc ME|PMD: Year-over-year earnings per share growth for the last 12 months